Table 3.

Univariate Analysis of Risk Factors for Graft and Patient Survival

HR Graft loss (95% CI)HR Death (95% CI)
Deceased Donor Factors
    Age:
        ≥35 versus <351.27 (1.12–1.44)b1.07 (0.88–1.31)
        ≥50 versus <351.45 (1.09–1.92)a0.79 (0.45–1.38)
    Race:
        AA versus White1.40 (1.21–1.63)b1.52 (1.21–1.91)b
        Other versus White0.99 (0.84–1.17)1.09 (0.84–1.40)
    BMI:
        >25–30 versus 20–251.13 (1.00–1.28)a1.54 (0.96–1.39)
        >30 versus 20–251.03 (0.84–1.27)1.08 (0.79–1.48)
    Gender: Male0.95 (0.85–1.06)1.11 (0.93–1.32)
    Death:
        CVA versus Head Trauma1.23 (1.09–1.40)a1.16 (0.96–1.41)
        Other versus Head Trauma1.32 (1.11–1.58)a1.25 (0.96–1.63)
Recipient/Transplant Factors:
    Age:
        ≥35 versus <350.77 (0.69–0.87)b1.21 (1.00–1.47)a
        ≥50 versus <351.00 (0.85–1.18)2.13 (1.67–2.71)b
    Race: AA versus White1.52 (1.31–1.76)b1.14 (0.89–1.45)
        Other versus White0.96 (0.78–1.78)0.74 (0.52–1.04)
    Previous Kidney Transplant1.22 (0.98–1.51)1.23 (0.89–1.70)
    Subsequent Pancreas Transplant (PAK)0.96 (0.81–1.15)1.23 (0.96–1.59)
Peak PRA >01.02 (0.92–1.13)1.23 (0.89–1.70)
    Pre-Transplant Dialysis:
        <12m versus None1.15 (0.99–1.34)1.11 (0.88–1.40)
        >12–24m versus None1.17 (1.01–1.36)a1.14 (0.90–1.43)
        >24m versus None1.41 (1.22–1.63)b1.49 (1.20–1.86)b
    CIT
        12–23 h versus <12 h0.97 (0.86–1.10)0.90 (0.75–1.07)
        24 ≤ 36 h versus <12 h1.15 (0.91–1.44)1.23 (0.88–1.71)
    Zero HLA Mismatch1.09 (0.88–1.34)1.50 (1.34–1.98)a
    Delayed Graft Function1.72 (1.45–2.03)b1.77 (1.38–2.28)b
    Acute Rejection1.22 (1.08–1.37)a0.89 (0.74–1.09)
    Era of Transplant:2001–2005 versus 1997–20000.79 (0.70–0.89)b0.60 (0.50–0.73)b